Cited by 14Artificial Intelligence in Healthcare and EducationRetinal Imaging and AnalysisOphthalmology and Visual Health Research

Patient and practitioner perceptions around use of artificial intelligence within the English NHS diabetic eye screening programme

Open access
Wahlich, Charlotte, Chandrasekaran, Lakshmi, Chaudhry, Umar A.R., Willis, Kathryn, Chambers, Ryan, Bolter, Louis, Anderson, John, Shakespeare, Royce +8 more·2025·Diabetes Research and Clinical Practice

Abstract

AIMS: Automated retinal image analysis using Artificial Intelligence (AI) can detect diabetic retinopathy as accurately as human graders, but it is not yet licensed in the NHS Diabetic Eye Screening Programme (DESP) in England. This study aims to assess perceptions of People Living with Diabetes (PLD) and Healthcare Practitioners (HCP) towards AI's introduction in DESP. METHODS: Two online surveys were co-developed with PLD and HCP from a diverse DESP in North East London. Surveys were validated through interviews across three centres and distributed via DESP centres, charities, and the British Association of Retinal Screeners. A coding framework was used to analyse free-text responses. RESULTS: 387 (24%) PLD and 98 (37%) HCP provided comments. Themes included trust, workforce impact, the patient-practitioner relationship, AI implementation challenges, and inequalities. Both groups agreed AI in DESP was inevitable, would improve efficiency, and save costs. Concerns included job losses, data security, and AI decision safety. A common misconception was that AI would directly affect patient interactions, though it only processes retinal images. CONCLUSIONS: Limited understanding of AI was a barrier to acceptance. Educating diverse PLD groups and HCP about AI's accuracy and reliability is crucial to building trust and facilitating its integration into screening practices.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2024.111964

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Concerns about data security are a barrier to AI adoption in diabetes management.

    “Another fundamental barrier to consider is the concern about data security, liability, and how the system made the decision (black box problem) [54,55,57].”

    From Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers’ Perspective: A Scoping Review (2025) · cites this paper as [57]

    Section 3.1.4 (page unavailable) reports data-security concerns and questions about who is responsible if AI misses disease; section 3.1.1 describes limited understanding of AI as a barrier to acceptance. These findings concern AI in diabetic eye screening, not diabetes management generally, and the copy does not specifically identify difficulty explaining an individual AI decision as a barrier. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Time-saving is a facilitator to AI adoption in diabetes management.

    “the time sparing effect, both for the patient and for the physician [53,56,57]”

    From Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers’ Perspective: A Scoping Review (2025) · cites this paper as [57]

    Section 3.1.8 (Efficiency; page unavailable) reports that patients and healthcare professionals expected AI to speed up diabetic eye screening and free staff for other tasks. Section 3.1.7 (Practicalities of AI implementation; page unavailable) also records a patient's expectation of faster results. These are perceived benefits in eye screening, not demonstrated time savings for both patients and physicians across diabetes management. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Impact of a grading workload is a barrier in the implementation process domain.

    “and the impact of a grading workload [57].”

    From Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers’ Perspective: A Scoping Review (2025) · cites this paper as [57]

    Section 3.1.3 (Impact on the workforce; page unavailable) reports that practitioners expected AI to reduce graders’ workload but worried this could lead to job losses or cuts rather than reinvestment. This supports concern about the impact of changing grading workload, but the paper does not identify grading workload itself as a barrier in an ‘implementation process’ domain. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Doubts about reliability and accuracy negatively impact physician confidence in the AI system.

    “Finally, doubts about reliability and accuracy may negatively impact physician confidence in the system [56,57].”

    From Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers’ Perspective: A Scoping Review (2025) · cites this paper as [57]

    Sections 3.1.10 (Accuracy and reliability of AI technology) and 3.1.5 (Trust), with no page numbers available, report healthcare practitioners’ concerns about AI accuracy and reliability and state that AI errors could affect staff confidence. This supports the hedged link to confidence, but the paper discusses screening staff and other healthcare practitioners, not physicians specifically. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Diagnostic limitations of AI systems (they may not detect other conditions besides the one for which they have been designed) are a barrier to AI adoption.

    “whereas the studies of Wewetzer et al. [56] and Wahlich et al. [57] highlighted diagnostic limitations of AI systems (they may not detect other conditions besides the one for which they have been designed for, leading to incomplete diagnosis).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Zhelev ZPJ, Rogers M, et al. Automated grading in the diabetic eye screening programme: external review against programme appraisal criteria for the UK. In: National Screening Committee In: Committee UNS; 2021.
  2. Rudnicka A, et al. Evaluation of equity in performance of Artificial Intelligence for diabetic retinopathy (DR) detection. Invest Ophthalmol Vis Sci 2024;65(7):4922.

Cited by

Sorted by citations

Authors
Wahlich, C., Chandrasekaran, L., Chaudhry, U. A. R., Willis, K., Chambers, R., Bolter, L., Anderson, J., Shakespeare, R., Olvera-Barrios, A., Fajtl, J., Welikala, R., Barman, S., Egan, C. A., Tufail, A., Owen, C. G., & Rudnicka, A. R.
Affiliations
  • University of London (GB)
  • City St George's, University of London (GB)
  • Homerton University Hospital NHS Foundation Trust (GB)
  • Kingston University London (GB)
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
Corresponding author
Wahlich, Charlotte
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2025-01
Volume
219
Pages
111964
ISSN
0168-8227 (ISSN-L)
OpenAlex
W4405613484
Cited by
13
References
17
Citations by year
2026: 10 · 2025: 3
FWCI
1.22
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Repository (Kingston University London) (acceptedVersion)
  • St George's Online Research Archive (St George's University of London) (submittedVersion)
Funders
  • University Hospitals Birmingham NHS Foundation Trust
  • Queen Elizabeth Hospital Birmingham Charity
  • Diabetes Research and Wellness Foundation
  • Diabetes UK
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
Keywords
artificial intelligence, diabetic retinopathy, diabetic retinopathy screening, automated retinal analysis, patient perspectives, trust in AI, workforce impact, patient-practitioner relationship, data security, health disparities, diabetes screening, National Health Service
MeSH terms
Aged, Artificial Intelligence, Attitude of Health Personnel, Diabetic Retinopathy, England, Female, Health Personnel, Humans, Male, Mass Screening, Middle Aged, Surveys and Questionnaires, State Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review